| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 20, 2018Revenue of $7.4 Billion Increased 1% as Reported; 7% at Comparable, Constant Currency
DUBLIN - February 20, 2108 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2018, which ended January 26, 2018. The company reported third quarter...
-
Feb 16, 2018
DUBLIN - February 16, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the CECP CEO Investor Forum 3.0 in New York on Monday,...
-
Feb 15, 2018
DUBLIN and VIENNA - February 15, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that new data from its at-home pediatric study of the MiniMed(TM) 670G...
-
Feb 13, 2018Medtronic Will Host an Exclusive Symposium on Thursday, February 15
VIENNA - February 13, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the Advanced Technologies...
-
Feb 13, 2018
DUBLIN - February 13, 2018 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the third quarter of fiscal year 2018 on Tuesday, February 20, 2018. A news release...
-
Jan 30, 2018Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD
DUBLIN and LEIPZIG - January 30, 2018 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence supporting the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with new...
-
Jan 30, 2018Healthcare Leaders Join to Streamline and Optimize the Management of Lung Nodules
DUBLIN and AMSTERDAM - January 30, 2018 - In a collective effort to improve the management of patients with lung nodules, Medtronic plc (NYSE: MDT) and Royal Philips (NYSE: PHG; AEX: PHIA) have...
-
Jan 30, 2018
DUBLIN and SHANGHAI - January 30, 2018 - Medtronic plc (NYSE:MDT) today announced that Alex Gu, previously Vice President, Regional Growth Initiatives, Greater China, and leader of Medtronic's...
-
Jan 26, 2018Study to Enroll Subjects at up to 35 Sites Across the U.S. and Europe
DUBLIN - January 26, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of its investigational device exemption (IDE) study for the Abre(TM) venous self-expanding stent system. The...
-
Jan 24, 2018Clinical Study to Investigate the Performance of the ChEVAR Technique in AAA Patients with Short Aortic Necks
DUBLIN - January 24, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of the ENCHANT (ENdurant CHEVAR New Indication Trial) study. The post-market, non-interventional, multi-center,...
-
Jan 16, 2018New System Expands Neurovascular Product Portfolio for the Treatment of Acute Ischemic Stroke
DUBLIN - January 16, 2018 - Medtronic plc (NYSE:MDT) today announced that the company's Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM)...
-
Jan 11, 2018Therapy Delivered via the Medtronic SynchroMed(TM) II Infusion System
DUBLIN - January 11, 2018 - Medtronic plc (NYSE:MDT) today announced the publication of results from the 'Spasticity In Stroke-Randomised Study' (SISTERS) trial in the Journal of Neurology,...
-
Jan 10, 2018SynchroMed(TM) II for Chronic Pain Is an Alternative to Systemic Opioids for Many Patients
DUBLIN - January 10, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of a new clinician programmer for use with the SynchroMed(TM)II Intrathecal...
-
Jan 9, 2018As More Physicians Seek Non-Opioid Treatment Options, the Vectors Study Will Further Advance Understanding of New Approaches to Optimal Spinal Cord Stimulation Treatment
DUBLIN - January 9, 2018 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Vectors Post Market Clinical Study. The study will follow patients with chronic intractable...
-
Dec 29, 2017
DUBLIN - December 29, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 36th Annual J.P. Morgan Healthcare Conference on Monday,...
-
Dec 19, 2017Bryan Hanson Leaves Medtronic to Become President and CEO of a Public Company
DUBLIN - December 19, 2017 - Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic's Asia Pacific (APAC) Region, has been named...
-
Dec 8, 2017
DUBLIN - December 8, 2017 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 third quarter cash dividend of $0.46 per ordinary share, representing a 7 percent...
-
Dec 1, 2017
DUBLIN - December 1, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Citi 2017 Global Healthcare Conference on Wednesday,...
-
Nov 27, 2017Medtronic Care Management Services Delivers on Its Commitment to Serve Veteran Patients with Expanded Suite of Telehealth Solutions
DUBLIN - November 27, 2017 - Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business commenced launch of new telehealth solutions in support of its national...
-
Nov 21, 2017Revenue of $7.1 Billion; GAAP Diluted EPS of $1.48; Non-GAAP Diluted EPS of $1.07
DUBLIN - November 21, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2018, which ended October 27, 2017. The company reported second...
-
Nov 20, 2017Azure(TM) with BlueSync(TM) Technology Improves Device Longevity and Provides Automatic, Wireless Remote Patient Monitoring
DUBLIN - November 20, 2017 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with...
-
Nov 13, 2017
DUBLIN - November 13, 2017 - Medtronic plc (NYSE: MDT) today announced several noteworthy presentations of clinical studies and symposia on aortic, peripheral, endoVenous, and vascular...
-
Nov 8, 2017Preliminary Revenue of Approximately $7.1 Billion
DUBLIN - November 8, 2017 - Medtronic plc (NYSE: MDT) today announced its preliminary revenue for its second quarter of fiscal year 2018, which ended October 27, 2017. The company announced...
-
Nov 6, 2017New Neurostimulation System Is a Non-Opioid Alternative for Chronic Pain and Offers Personalized Pain Relief and Advanced Activity Tracking
DUBLIN - November 6, 2017 - Medtronic plc (NYSE:MDT) today announced that it received CE (Conformité Européenne) Mark for the Intellis(TM) platform for both Spinal Cord Stimulation (SCS) and...
-
Nov 2, 2017Evolut PRO Valve Well-Positioned for Future with New Study Unveiled to Investigate Expanded Patient Population
DUBLIN and DENVER - November 2, 2017 - Medtronic plc (NYSE:MDT) today presented new data at the Transcatheter Cardiovascular Therapeutics (TCT) Annual Meeting showcasing the excellent clinical...